M9140 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Also known as: Precemtabart tocentecan

Pipeline

Phase 1: 1

Top Sponsors

EMD Serono Research & Development Institute, Inc.1

Indications

Colorectal Cancer1
Cancer1

Encinitas, California1 trial

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

California Cancer Associates for Research & Excellence, Inc.

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.